Profile for European Patent Office Patent: 2316456
✉ Email this page to a colleague
| Country | SPC | SPC Expiration |
|---|---|---|
| Denmark | CA 2017 00062 | ⤷ Start Trial |
| Netherlands | 300918 | ⤷ Start Trial |
| Germany | 122017000109 | ⤷ Start Trial |
| Luxembourg | LUC00054 | ⤷ Start Trial |
| Belgium | 2017C/064 | ⤷ Start Trial |
| Denmark | CR 2017 00062 | ⤷ Start Trial |
| Sweden | 1790064-8 | ⤷ Start Trial |
US Patent Family Members and Approved Drugs for European Patent Office Patent: 2316456
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
